BACKGROUND: Kaposi's sarcoma (KS) is a rare neoplasm of lymphatic endothelial cells. Human herpes virus 8 (HHV-8) is considered to be a necessary, but not sufficient causal agent of KS and additional cofactors remain unknown. In this study we evaluated the expression of human β defensin (HBD)-3 and LL-37 in cutaneous lesions of KS in comparison to the healthy skin of normal subjects. METHODS: We performed a quantitative immunohistochemical study of HBD-3 and LL-37 on skin lesions from 18 patients having KS, and on healthy skin from 12 normal controls. RESULTS: HBD-3 and LL-37 were significantly upregulated in epidermal and dermal specimens of all KS patients in comparison to normal skin of healthy controls. The immunostaining score of dermal HBD-3 was significantly higher in nodular lesions (9.6 ± 2.4) versus plaque lesions (4.1 ± 2.2), P = 0.001. Also the immunostaining score of dermal LL-37 was significantly higher in nodular lesions versus plaque lesions (P = 0.001). CONCLUSIONS: We have demonstrated for the first time that HBD-3 and LL-37 are significantly upregulated in lesional skin of KS in comparison to the skin of healthy controls. The obtained data suggest a possible involvement of these antimicrobial peptides in the pathogenesis of KS. However, the biological significance of HBD-3 and LL-37 in KS lesions needs further research.
BACKGROUND:Kaposi's sarcoma (KS) is a rare neoplasm of lymphatic endothelial cells. Human herpes virus 8 (HHV-8) is considered to be a necessary, but not sufficient causal agent of KS and additional cofactors remain unknown. In this study we evaluated the expression of human β defensin (HBD)-3 and LL-37 in cutaneous lesions of KS in comparison to the healthy skin of normal subjects. METHODS: We performed a quantitative immunohistochemical study of HBD-3 and LL-37 on skin lesions from 18 patients having KS, and on healthy skin from 12 normal controls. RESULTS:HBD-3 and LL-37 were significantly upregulated in epidermal and dermal specimens of all KS patients in comparison to normal skin of healthy controls. The immunostaining score of dermal HBD-3 was significantly higher in nodular lesions (9.6 ± 2.4) versus plaque lesions (4.1 ± 2.2), P = 0.001. Also the immunostaining score of dermal LL-37 was significantly higher in nodular lesions versus plaque lesions (P = 0.001). CONCLUSIONS: We have demonstrated for the first time that HBD-3 and LL-37 are significantly upregulated in lesional skin of KS in comparison to the skin of healthy controls. The obtained data suggest a possible involvement of these antimicrobial peptides in the pathogenesis of KS. However, the biological significance of HBD-3 and LL-37 in KS lesions needs further research.
Authors: J E Kim; H J Kim; J M Choi; K H Lee; T Y Kim; B K Cho; J Y Jung; K Y Chung; D Cho; H J Park Journal: Br J Dermatol Date: 2010-11 Impact factor: 9.302
Authors: W Erhart; Ö Alkasi; G Brunke; F Wegener; N Maass; N Arnold; A Arlt; I Meinhold-Heerlein Journal: J Infect Dis Date: 2011-07-05 Impact factor: 5.226
Authors: Johan D Heilborn; Margareta Frohm Nilsson; Clara I Chamorro Jimenez; Bengt Sandstedt; Niels Borregaard; Emma Tham; Ole E Sørensen; Günther Weber; Mona Ståhle Journal: Int J Cancer Date: 2005-05-01 Impact factor: 7.396
Authors: V Fiorelli; R Gendelman; M C Sirianni; H K Chang; S Colombini; P D Markham; P Monini; J Sonnabend; A Pintus; R C Gallo; B Ensoli Journal: Blood Date: 1998-02-01 Impact factor: 22.113
Authors: Judith von Haussen; Rembert Koczulla; Renat Shaykhiev; Christian Herr; Olaf Pinkenburg; Dietlind Reimer; Rainer Wiewrodt; Stefan Biesterfeld; Achim Aigner; Frank Czubayko; Robert Bals Journal: Lung Cancer Date: 2007-08-31 Impact factor: 5.705
Authors: Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals Journal: J Clin Invest Date: 2003-06 Impact factor: 14.808